Skip to main content
Clinical Trials/NCT04793048
NCT04793048
Unknown
N/A

A Randomized, Double-blind, Controlled Study to Evaluate the Safety and Feasibility of a Noninvasive Intraoral Electrotherapy Device for the Treatment of Patients With Periodontitis

Shanghai Keku Medical Technology Co., Ltd.0 sites30 target enrollmentMarch 22, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Periodontal Diseases
Sponsor
Shanghai Keku Medical Technology Co., Ltd.
Enrollment
30
Primary Endpoint
Reductions in the probing depth
Last Updated
5 years ago

Overview

Brief Summary

A parallel-armed, sham-controlled, and participant-blind pilot study will be conducted to determine the safety and effectiveness of use of a noninvasive intraoral electrotherapy device to treat periodontal disease. A total of 30 patients were randomly assigned to one of two groups. The trial was comprised of three in-office oral examinations, which were performed at baseline, and at follow-ups~6 weeks (42 days ± 3 days) and~3months (84 days ± 3 days later).

Detailed Description

A parallel-armed, sham-controlled, and participant-blind pilot study will be conducted to determine the safety and effectiveness of use of a noninvasive intraoral electrotherapy device to treat periodontal disease at-home for 20 minutes a day. A total of 30 patients were randomly assigned to one of two groups: one group received an active intraoral electrotherapy device and a scaling and root planing (SRP) at baseline, another group received a sham device and a scaling and root planing (SRP) at baseline. The trial was comprised of three in-office oral examinations, which were performed at baseline, and at follow-ups~6 weeks (42 days ± 3 days) and~3months (84 days ± 3 days later). After 3 months of treatment, the effectiveness of the intraoral electrotherapy device would be demonstrated by (1) statistically superior reductions in the probing depth and clinical attachment level compared to treatment with the sham device. (2) statistically superior reductions in the bleeding on probing and gingival index compared to treatment with the sham device.

Registry
clinicaltrials.gov
Start Date
March 22, 2021
End Date
November 30, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Reductions in the probing depth

Time Frame: 3 months

Reductions in the clinical attachment level

Time Frame: 3 months

Secondary Outcomes

  • Reductions in the bleeding on probing and gingival index(3 months)

Similar Trials